Cardiovascular

NeoProfen recalled

Lundbeck Inc. has recalled two lots of NeoProfen (ibuprofen lysine) that failed to meet a visible particulate quality requirement. NeoProfen is used to close a clinically significant patent ductus arteriosus (PDA) in premature infants. Read more here.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares